Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA denies Public Citizen's petition against Meridia

Aug. 22, 2005

MD-0727 reduces liver cholesterol accumulation in hamsters by more than 90%

Aug. 22, 2005

Progress in extended collaboration between Karo Bio and Wyeth

Aug. 22, 2005

Subcutaneous and buccal spray insulin induce similar effects in patients with type 1 diabetes

Aug. 22, 2005

Oxytocin receptor antagonists in the prevention of preterm labor

Aug. 18, 2005

FDA approval for Fortical

Aug. 17, 2005

Corautus Genetics signs agreements for VEGF-2 for diabetic neuropathy

Aug. 17, 2005

ChemGenex receives grants for diabetes research

Aug. 17, 2005

New agents for treating obesity disclosed by Procter & Gamble

Aug. 16, 2005

Velcura and Nippon Chemiphar collaborate on osteoporosis drugs

Aug. 16, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...